Summit X LLC’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q4
Sell
-575
Closed -$335 287
2020
Q3
$335 Buy
+575
New +$335 0.01% 350